Free provider profile

JAMAL MISLEH, MD

NPI 1174665822
Individual
Internal Medicine, Hematology & Oncology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like JAMAL MISLEH?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What JAMAL MISLEH prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Lenalidomide
  • Imbruvica
  • Jakafi
  • Calquence
  • Revlimid

See all hematologist-oncologists in DE who bill Medicare →

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

302-366-1200

Fax

302-366-1700

Practice address

4701 OGLETOWN STANTON RD SUITE 3400, NEWARK, DE, 19713

Registry updated
2009-06-15
NPI issued
2007-02-12
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

4701 OGLETOWN STANTON RD SUITE 3400, NEWARK, DE, 19713

302-366-1200

Single practice location

Enumerated 2007-02-12

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — Record last updated 17 years ago.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

2,585

Medicare patients

362

Part D drug cost

$9,130,211

Brand-name share

Not published

of this prescriber's Part D claims

DrugClaimsMedicare cost
Lenalidomide (Lenalidomide)135$2,056,555
Imbruvica (Ibrutinib)75$1,224,608
Jakafi (Ruxolitinib Phosphate)45$754,992
Revlimid (Lenalidomide)42$669,263
Calquence (Acalabrutinib Maleate)45$649,272
Xpovio (Selinexor)14$422,768
Pomalyst (Pomalidomide)27$415,572
Ibrance (Palbociclib)21$331,766

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across DE — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.